Skip to main content
FNIH Logo
FNIH Logo
Home

Main navigation

  • Our Value
    • Advancing Biomedical Innovation
    • Why Our Work Matters
    • Our Promise
  • Our Programs
    • All Programs
    • Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
    • Accelerating Medicines Partnership® Program (AMP)
    • Awards, Prizes, and Events
    • Biomarkers Consortium
    • GeneConvene Global Collaborative
  • Our People
    • Board of Directors and Governance
    • Staff
  • Let's Collaborate
    • Advancing Research
    • Advancing Scientists
    • Advancing Our Shared Mission

Utility

  • News
    • Press Releases
    • Announcements
    • Digital Timeline
  • Careers
  • Donate

Breadcrumb

  1. Home
  2. All Programs

All Programs

Refine Results View All Programs

Refine Results

Popular
Program Type
Topic Area
Project Status
Government Entities
  • Research x
  • Kidney Disease
  • Child Health
  • Vascular Disease
  • Liver Disease x
  • Neurodevelopmental Disorders x
  • Active Projects
  • Completed Projects
  • Food and Drug Administration
  • National Cancer Institute (NCI)
  • National Institute of Mental Health (NIMH)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • National Center for Advancing Translational Sciences (NCATS)
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • National Institutes of Health (NIH) x
3 Results
Research

Accelerating Medicines Partnership® Program – Schizophrenia

Research

Biomarkers Consortium - Workshop: Developing an Evidentiary Criteria Framework for Safety Biomarkers Qualification

Research

Biomarkers Consortium - Workshop: Defining an Evidentiary Criteria Framework for Surrogate Endpoint Qualification

Follow Us

  • Facebook
  • Twitter
  • Youtube
  • LinkedIn

Footer

  • Privacy Policy
  • Terms of Use
  • State Nonprofit Disclosures
  • NIH
  • Financials & Annual Reports
  • Equity, Diversity and Inclusion
  • Contact

Four Stars from Charity Navigator